Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Villain

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Environmental Technology|April 11, 2018
Key process parameters involved in the treatment of olive mill wastewater by membrane bioreactorY Jaouad, M Villain-Gambier, L Mandi, et al.
Environmental Technology|April 24, 2018
Fractionation of polyphenols from thermomechanical pulp mill process water by flotation and membrane integrated processM Courbalay, M Villain-Gambier, A Klem, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2000
A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell helpS Araga, L Xu, K Nakashima, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1997
[Anesthesia with the laryngeal mask during the treatment of fractures of the nose. A study of a group of 53 patients]M Villain, P Jammet, R Thomasset, et al.
Journal Francais D'Ophtalmologie|June 19, 2009
[Acute diplopia after the age of 50; always look for giant cell arteritis]V Daïen, S Rivière, A Konaté, et al.
Experimental Eye Research|April 1, 1997
Free radicals in rabbit retina under ocular hyperpressure and functional consequencesA Muller, S Pietri, M Villain, et al.
Journal Francais D'Ophtalmologie|August 29, 2012
[Infectious complications in patients treated with anti-TNF-alpha: two cases of leishmaniasis]E Bousquet, F Mura, M Villain, et al.
Cellular Immunology|May 3, 2001
Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cellsL Xu, M Villain, F S Galin, et al.
Bioresource Technology|February 27, 2026
Purification process coupling membrane filtration and adsorption for deep eutectic solvent (DES) recycling after lignin extractionP L Pasquet, Y Abdou, M Villain-Gambier, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1996
Differential effect of ischemia/reperfusion on pigmented and albino rabbit retinaA Muller, M Villain, B Favreau, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Environmental Technology|April 11, 2018
Key process parameters involved in the treatment of olive mill wastewater by membrane bioreactorY Jaouad, M Villain-Gambier, L Mandi, et al.
Environmental Technology|April 24, 2018
Fractionation of polyphenols from thermomechanical pulp mill process water by flotation and membrane integrated processM Courbalay, M Villain-Gambier, A Klem, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2000
A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell helpS Araga, L Xu, K Nakashima, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|January 1, 1997
[Anesthesia with the laryngeal mask during the treatment of fractures of the nose. A study of a group of 53 patients]M Villain, P Jammet, R Thomasset, et al.
Journal Francais D'Ophtalmologie|June 19, 2009
[Acute diplopia after the age of 50; always look for giant cell arteritis]V Daïen, S Rivière, A Konaté, et al.
Experimental Eye Research|April 1, 1997
Free radicals in rabbit retina under ocular hyperpressure and functional consequencesA Muller, S Pietri, M Villain, et al.
Journal Francais D'Ophtalmologie|August 29, 2012
[Infectious complications in patients treated with anti-TNF-alpha: two cases of leishmaniasis]E Bousquet, F Mura, M Villain, et al.
Cellular Immunology|May 3, 2001
Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cellsL Xu, M Villain, F S Galin, et al.
Bioresource Technology|February 27, 2026
Purification process coupling membrane filtration and adsorption for deep eutectic solvent (DES) recycling after lignin extractionP L Pasquet, Y Abdou, M Villain-Gambier, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1996
Differential effect of ischemia/reperfusion on pigmented and albino rabbit retinaA Muller, M Villain, B Favreau, et al.
Pageof 7